| Why Is Tenax Therapeutics (TENX) Stock Up 29% Today? | 08/06 11:05 | investorplace.com |
| Tenax Therapeutics Announces Oversubscribed $100 Million Private Placement | 08/06 07:13 | globenewswire.com |
| Tenax Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update | 05/14 08:00 | globenewswire.com |
| Tenax Therapeutics Announces New U.S. Patent Covering the Use of Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF) | 04/30 07:30 | globenewswire.com |
| Tenax Therapeutics to Host KOL Event: “LEVEL Setting: the Scientific Rationale for Levosimendan as a Potential First Treatment for PH-HFpEF, and the Ongoing Phase 3 LEVEL Study” | 04/09 08:30 | globenewswire.com |
| Tenax Therapeutics Provides Business and Clinical Development Updates with Full Year 2023 Financial Results | 03/28 08:30 | globenewswire.com |
| Tenax Therapeutics to Present at the 36th Annual Roth Conference | 03/12 08:30 | globenewswire.com |
| Tenax Therapeutics Announces Oral Presentation of Levosimendan for the Treatment of PH-HFpEF at THT 2024 | 02/29 09:00 | globenewswire.com |
| Tenax Therapeutics Announces Global License Amendment that Significantly Expands Rights to Levosimendan | 02/20 08:30 | globenewswire.com |
| Why Is Tenax Therapeutics (TENX) Stock Down 64% Today? | 02/08 08:53 | investorplace.com |